Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Evaxion
Evaxion announces business update and first quarter 2026 financial results
May 25, 2026
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
May 24, 2026
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
May 23, 2026
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
May 22, 2026
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
May 22, 2026
Evaxion concludes Annual General Meeting
May 22, 2026
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
May 20, 2026
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
May 19, 2026
Notice to convene Evaxion’s Annual General Meeting
May 17, 2026
Evaxion to present new data at AACR Annual Meeting
May 17, 2026